Bafna Pharmaceuticals Ltd Share Price Bafna Pharma.

8.10

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

7.80

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 31-Jan-2019 - -
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2019 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, 08th February 2019 at the registered office of the Company, to inter alia consider and adopt un-audited financial results for the quarter ended 31st December 2018 and any other business with the permission of the Chair. We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the Third Quarter ending 31st December 2018. Please find attached the un-audited financial results for Third Quarter ending 31st December 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. Appointment of Mr. Babulal Kamlesh Kumar (DIN: 01218959) as an Independent Director with effect from 08th February 2019 (Annexure-1) The meeting commenced at 3.00 PM and concluded at 6.45 P.M We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the Third Quarter ending 31st December 2018. Please find attached the un-audited financial results for Third Quarter ending 31st December 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the Third Quarter ending 31st December 2018. Please find attached the un-audited financial results for Third Quarter ending 31st December 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. Appointment of Mr. Babulal Kamlesh Kumar (DIN: 01218959) as an Independent Director with effect from 08th February 2019 (Annexure-1) The meeting commenced at 3.00 PM and concluded at 6.45 P.M (As Per BSE Announcement Dated 08.02.2019)
Board Meeting - 05-Nov-2018 - -
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, 13th November 2018 at the registered office of the Company, to inter alia consider and adopt un-audited financial results for the quarter ended 30th Sep 2018 and any other business with the permission of the Chair. We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the quarter / half year ending 30th September 2018. Please find attached the un-audited financial results for quarter / half year ending 30th September 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. The meeting commenced at 3.00 PM and concluded at 6.45 P.M We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the quarter / half year ending 30th September 2018. Please find attached the un-audited financial results for quarter / half year ending 30th September 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. The meeting commenced at 3.00 PM and concluded at 6.45 P.M (As Per BSE Announcement Dated On 13/11/2018)
Board Meeting - 03-Sep-2018 - -
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that, the Board of Directors of the Company in its meeting held on today i.e 05th September , 2018, inter alia transacted the following: 1. Annual General Meeting: The 23rd AGM of the Company is scheduled to be held on Saturday, the 29th of September, 2018, at 10.00 A.M 2. Book Closure: BSE Security Code NSE Symbol Type of Security Book closure (both days inclusive) Cut off date purpose from To 532989 BAFNAPHARM Equity 23-09-2018 29-09-2018 22-09-2018 Annual General Meeting 3. E-voting: shall remain open from 09.00 A.M on 26.09.2018 to 05.00 P.M on 28.09.2018 (both days inclusive) 4. Resignation of Mr. R. Dwarkanathan Ramachandra (DIN-01933653) as Director with effect from 21st Aug 2018. (As Per BSE Announcement Dated On 06/09/2018)
Board Meeting - 06-Aug-2018 - -
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday, 13th Aug 2018 at the registered office of the Company, to inter alia consider and adopt un-audited financial results for the quarter ended 30th June 2018 and any other business with the permission of the Chair. We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the quarter ending 30th June 2018. Please find attached the un-audited financial results for the first quarter ending 30th June 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. The meeting commenced at 7.30 PM and concluded at 8.30 PM (As Per BSE Announcement Dated on 13.08.2018)
Board Meeting - 22-May-2018 - -
Audited Results The meeting of the Board of Directors of the Company is scheduled to be held on Monday, the 28th May 2018 to consider the Unaudited Financial Results for the quarter & year ended 31st March 2018. The meeting of the Board of Directors of the Company is scheduled to be held on Monday, the 28th May 2018 to consider the Unaudited Financial Results for the quarter & year ended 31st March 2018. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that, the Board of Directors of the Company in their meeting held on Monday, the 28th day of May, 2018 which commenced at 3.30 PM and concluded at 7.00 PM, inter alia transacted the following: 1. Considered and approved Financial Statements for the year ended 31st March, 2018. 2. Resignation of Mr. Nirav Vikram Maniar, Additional Director with effect from 28th May 2018. 3. Resignation of Ms. Nirmala L, Company Secretary with effect from 31st May 2018. 4. Appointment of Mr. Jitendra Kumar Pal as Company Secretary with effect from 01st June 2018. This is for your information and records. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, We wish to inform you that, the Board of Directors of the Company in their meeting held on Monday, the 28th May, 2018 has considered & approved the resignation of the following Directors: 1. Mr. B Kamlesh Kumar, Director with effect from 20th May 2018(Date of Resignation). 2. Mr. Nirav Vikram Maniar, Additional Director with effect from 28th May 2018. Further, they will be relieved from the services of the Company at the close of office hours with effect from 28th May 2018. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, We wish to inform you that, the Board of Directors of the Company in their meeting held on Monday, the 28th May, 2018 has considered & approved the resignation of Ms. Nirmala L, Company Secretary from the company and she will be relieved from the services of the Company with effect from 31st May 2018. We wish to inform you that the Nomination & Remuneration Committee of the company recommended to appoint Mr. Jitendra Pal, Company Secretary. The Board of Directors in their meeting held on 28th May, 2018 has appointed Mr. Jitendra Pal, as the Company Secretary and Compliance Officer of the Company with effect from 01st June 2018 . The Audited Financial results for the quarter and Year ended 31st March 2018 has been adopted and approved by the Audit Committee and Board of Directors in the meeting held today. (As per BSE Announcement dated on 28/05/2018)